VMD Share Price Performance
US$6.76
-1.96 (-22.48%)
38.5% undervalued intrinsic discount
US$11.00
Fair Value
Price US$6.76
AnalystLowTarget US$11.00
AnalystHighTarget US$12.71
AnalystConsensusTarget US$13.00
Fair ValueUS$11.00
Share Pricen/a
Viemed Healthcare, Inc. Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 22 Fair Values set on narratives written by author
VMD Community Narratives
AN
Fair Value US$11 38.5% undervalued intrinsic discount
Medicare Pressures And Competition Will Test Margins Yet Improve Resilience
0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
AN
Fair Value US$15 54.9% undervalued intrinsic discount
US Aging And Telehealth Will Expand Home Care
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Fair Value US$13 48.0% undervalued intrinsic discount
Ventilation, Sleep Therapy, And Maternal Health Will Expand Reach
0users have liked this narrative
0users have commented on this narrative
9users have followed this narrative
Medicare Pressures And Competition Will Test Margins Yet Improve Resilience
Key Takeaways Heavy dependence on Medicare reimbursement and traditional care models exposes Viemed to margin pressure and risks from regulatory and technological changes in home healthcare. Limited diversification and rising competition from larger, integrated providers threaten Viemed's long-term revenue growth and market position, especially as industry practices evolve.Read more
0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
AN
US$11
38.5% undervalued intrinsic discount
AnalystLowTarget Fair Value
Revenue
18.86% p.a.
Profit Margin
7.02%
Future PE
17.93x
Price in 2028
US$13.27
US Aging And Telehealth Will Expand Home Care
Key Takeaways Accelerating growth and operational efficiency, driven by tech automation, new therapies, and expanding market share, position Viemed for significant earnings margin expansion. Strategic acquisitions, population aging, and regulatory shifts enable multi-segment revenue growth and a durable competitive advantage as care and monitoring digitize.Read more
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
US$15
54.9% undervalued intrinsic discount
AnalystHighTarget Fair Value
Revenue
18.85% p.a.
Profit Margin
7.02%
Future PE
24.45x
Price in 2028
US$18.1
Ventilation, Sleep Therapy, And Maternal Health Will Expand Reach
Key Takeaways Leadership in in-home ventilation and rapid growth in complementary services are strengthening Viemed's revenue mix and improving margins. Acquisitions, regulatory tailwinds, and tech investments support geographic expansion and position the company for stable, diversified long-term growth.Read more
0users have liked this narrative
0users have commented on this narrative
9users have followed this narrative
AN
US$13
48.0% undervalued intrinsic discount
AnalystConsensusTarget Fair Value
Revenue
18.64% p.a.
Profit Margin
6.53%
Future PE
22.9x
Price in 2028
US$15.69
Trending Discussion
Recently Updated Narratives
AN
Ventilation, Sleep Therapy, And Maternal Health Will Expand Reach
Fair Value: US$13 48.0% undervalued intrinsic discount
9 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Medicare Pressures And Competition Will Test Margins Yet Improve Resilience
Fair Value: US$11 38.5% undervalued intrinsic discount
3 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
US Aging And Telehealth Will Expand Home Care
Fair Value: US$15 54.9% undervalued intrinsic discount
0 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Viemed Healthcare, Inc. Key Details
About VMD
- Founded
- 2006
- Employees
- 1380
- CEO
- WebsiteView website
Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. It also sells and rents HME devices, such as non-invasive and invasive ventilators, positive airway pressure (PAP) machines, durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment. In addition, the company provides neuromuscular care and oxygen therapy services; and sleep apnea management that provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.
